Clinical Trial Update: Prevalence of Genetic Mutations in Patients With Neuropathy Associated With Anti-Myelin-associated Glycoprotein (MAG) Antibodies

View source ↗

Summary

A completed clinical trial evaluating how common genetic mutations are among patients with neuropathy associated with MAG antibodies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anti-mag Antibody Neuropathy
• Demyelinating Polyneuropathy

Snippet

Sponsor: Rennes University Hospital | Conditions: Neuropathy Demyelinating | Status: COMPLETED